The MRC and the Japan Agency for Medical Research and Development (AMED) are pleased to announce they will soon be launching a joint call for research proposals focused on Regenerative Medicine and Stem Cell Research.
This initiative will support collaborative (UK-Japanese) research projects that build upon fundamental insights and initial early-stage discoveries, to advance regenerative approaches towards clinical use in the future and to utilise stem cells as medial research tools.
Applications will be particularly welcome for projects focusing on:
- Human cell engineering, gene editing and cellular reprogramming approaches where a clear future therapeutic goal has been identified.
- Investigations into modulation of the human tissue niche, or improving understanding of the niche; this may include for example establishing mechanisms for differentiation in transplanted stem cells or understanding immunological barriers.
- Improving efficacy of engraftment and regeneration of transplanted cells.
- Developing tools, technologies and methods to enable translational regenerative medicine research including, but not limited to, in-vivo cell imagining approaches or high throughput screening techniques.
- Creating novel on-vitro models utilising stem cells which could be used for robust predictive safety testing or as drug screening models.
Alternative project outcomes such as therapeutic candidates, medical devices and diagnostic agents mat also be supported by this call.
MRC will make up to £5m available to support the UK component of the collaborative research projects. It is expected that the available funds will support approximately 8 projects/
For further details and updates please visit the MRC and AMED websites in December.